Pharma and PBMs must jointly face insulin price fixing lawsuit for first time

Pharma and PBMs must jointly face insulin price fixing lawsuit for first time

STAT Plus: For the first time, drug makers and PBMs must jointly face an insulin price fixing lawsuit

By ED SILVERMAN

ADOBE

“The truth is both groups of companies have been working together to create an artificial pricing system," said a lawyer for Harris County.

READ MORE